Show simple item record

dc.contributor.authorMbori-Ngacha, DA
dc.contributor.authorNduati, RW
dc.contributor.authorJohn, G
dc.contributor.authorReilly, M
dc.contributor.authorRichardson, B
dc.contributor.authorMwatha, A
dc.contributor.authorNdinya-Achola, JO
dc.contributor.authorBwayo, JJ
dc.contributor.authorKreiss, J
dc.date.accessioned2013-05-31T13:20:31Z
dc.date.available2013-05-31T13:20:31Z
dc.date.issued2002-11-21
dc.identifier.citationMbori-ngacha D, Nduati R, John G, Reilly M, Richardson B, Mwatha A, Ndinya-achola J, Bwayo J, Kreiss J.morbidity And Mortality In Breastfed And Formula-fed Infants Of Hiv-1-infected Women: A Randomized Clinical Trial.jama. 2001 Nov 21;286(19):2413-20., O., Prof. Ndinya-achola J. , Jama. 2001 Nov 21;286(19):2413-20., (2001)en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/11712936
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/28412
dc.description.abstractCONTEXT: Breastfeeding among women infected with human immunodeficiency virus type 1 (HIV-1) is associated with substantial risk of HIV-1 transmission, but little is known about the morbidity risks associated with formula feeding in infants of HIV-1-infected women in resource-poor settings. OBJECTIVE: To compare morbidity, nutritional status, mortality adjusted for HIV-1 status, and cause of death among formula-fed and breastfed infants of HIV-1-infected women. DESIGN: Randomized clinical trial conducted between 1992 and 1998. SETTING: Four antenatal clinics in Nairobi, Kenya. PARTICIPANTS: Of 401 live-born, singleton, or first-born twin infants of randomized HIV-1-seropositive mothers, 371 were included in the analysis of morbidity and mortality. INTERVENTIONS: Mothers were randomly assigned either to use formula (n = 186) or to breastfeed (n = 185) their infants. MAIN OUTCOME MEASURES: Mortality rates, adjusted for HIV-1 infection status; morbidity; and nutritional status during the first 2 years of life. RESULTS: Two-year estimated mortality rates among infants were similar in the formula-feeding and breastfeeding arms (20.0% vs 24.4%; hazard ratio [HR], 0.8; 95% confidence interval [CI], 0.5-1.3), even after adjusting for HIV-1 infection status (HR, 1.1; 95% CI, 0.7-1.7). Infection with HIV-1 was associated with a 9.0-fold increased mortality risk (95% CI, 5.3-15.3). The incidence of diarrhea during the 2 years of follow-up was similar in formula and breastfeeding arms (155 vs 149 per 100 person-years, respectively). The incidence of pneumonia was identical in the 2 groups (62 per 100 person-years), and there were no significant differences in incidence of other recorded illnesses. Infants in the breastfeeding arm tended to have better nutritional status, significantly so during the first 6 months of life. CONCLUSIONS: In this randomized clinical trial, infants assigned to be formula fed or breastfed had similar mortality rates and incidence of diarrhea and pneumonia during the first 2 years of life. However, HIV-1-free survival at 2 years was significantly higher in the formula arm. With appropriate education and access to clean water, formula feeding can be a safe alternative to breastfeeding for infants of HIV-1-infected mothers in a resource-poor setting.en
dc.description.urihttp://www.ncbi.nlm.nih.gov/pubmed/11712936
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleMorbidity And Mortality In Breastfed And Formula-fed Infants Of Hiv-1-infected Women: A Randomized Clinical Trialen
dc.typeArticleen
local.publisherSchool of medicine (Paediatrics)en


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record